{
  "experiment": "Exp 4: Cross-Cancer SL Transferability",
  "hypothesis": "H3: SL relationships transfer across cancer lineages",
  "n_lineages_tested": 13,
  "lineages": [
    "ovary",
    "blood",
    "colorectal",
    "lung",
    "skin",
    "breast",
    "pancreas",
    "central_nervous_system",
    "bone",
    "lymphocyte",
    "kidney",
    "upper_aerodigestive",
    "liver"
  ],
  "n_transfer_tests": 150,
  "mean_transfer_rate": 0.10259154012921073,
  "n_universal_sl": 671,
  "top_universal_pairs": [
    {
      "driver_gene": "BRCA2",
      "target_gene": "RHEB",
      "n_lineages": 4,
      "lineages": "blood, colorectal, lung, central_nervous_system",
      "mean_effect": -0.3147019907909534,
      "min_effect": -0.3811160931152435
    },
    {
      "driver_gene": "BRCA2",
      "target_gene": "RARS1",
      "n_lineages": 4,
      "lineages": "blood, lung, skin, upper_aerodigestive",
      "mean_effect": -0.3612920721178251,
      "min_effect": -0.3889218334209529
    },
    {
      "driver_gene": "KRAS",
      "target_gene": "NARS2",
      "n_lineages": 4,
      "lineages": "blood, lung, skin, upper_aerodigestive",
      "mean_effect": -0.22979390378984235,
      "min_effect": -0.33854978771102284
    },
    {
      "driver_gene": "BRCA2",
      "target_gene": "PSMA4",
      "n_lineages": 4,
      "lineages": "blood, lung, skin, upper_aerodigestive",
      "mean_effect": -0.34118349224657973,
      "min_effect": -0.4220603162984513
    },
    {
      "driver_gene": "KRAS",
      "target_gene": "PPP4C",
      "n_lineages": 4,
      "lineages": "lung, skin, central_nervous_system, upper_aerodigestive",
      "mean_effect": -0.34063198639478054,
      "min_effect": -0.4371535797133772
    },
    {
      "driver_gene": "KRAS",
      "target_gene": "MRPL23",
      "n_lineages": 4,
      "lineages": "blood, lung, skin, central_nervous_system",
      "mean_effect": -0.28330747327013905,
      "min_effect": -0.3916157824267574
    },
    {
      "driver_gene": "KRAS",
      "target_gene": "MRPL16",
      "n_lineages": 4,
      "lineages": "ovary, blood, lung, skin",
      "mean_effect": -0.2244237051069902,
      "min_effect": -0.2830874330078804
    },
    {
      "driver_gene": "KRAS",
      "target_gene": "ADAT2",
      "n_lineages": 4,
      "lineages": "blood, lung, skin, upper_aerodigestive",
      "mean_effect": -0.22943096579382893,
      "min_effect": -0.27623620836248763
    },
    {
      "driver_gene": "KRAS",
      "target_gene": "RPP21",
      "n_lineages": 4,
      "lineages": "lung, skin, central_nervous_system, upper_aerodigestive",
      "mean_effect": -0.3056005835012962,
      "min_effect": -0.43756727378840976
    },
    {
      "driver_gene": "KRAS",
      "target_gene": "MRTO4",
      "n_lineages": 4,
      "lineages": "ovary, skin, central_nervous_system, upper_aerodigestive",
      "mean_effect": -0.35291067428122824,
      "min_effect": -0.39059381880862465
    }
  ],
  "hypothesis_supported": true,
  "conclusion": "H3 SUPPORTED: 671 SL pairs validated across \u22652 cancer lineages. Mean cross-lineage transfer rate: 10.3%. This suggests many SL relationships are conserved across cancer types, enabling broader therapeutic applications."
}